Our testing notes.
The compound roster here is genuinely interesting, and that's worth acknowledging. Androstadienone, the so-called 'love molecule' tied in some studies to elevated mood and emotional warmth in women around men, sits alongside copulins, the most primal female chemistry compound in common use, linked to increased male receptiveness. Androstenol adds social softness, and androstenone brings a harder edge. In the right ratios, these four could form a well-rounded female signature. The operative phrase is 'the right ratios.'
And Pherazone doesn't tell you the ratios. No concentrations, no per-compound dosing, no breakdown of how much of anything is in the cream. That matters enormously with copulins and androstenone, both dose-sensitive in ways that make 'some' a meaningless claim. Copulins at appropriate levels may increase male attentiveness. At too high a concentration they can read as overpowering and off-putting rather than attractive. Androstenone likewise needs careful calibration against the softer compounds. Without dosage data, you're applying something and hoping the formulator got it right, and Pherazone's track record doesn't inspire confidence that they did.
The cream format is a legitimate point of difference. It behaves differently on skin than a spray, with slower release and a different feel. And androstadienone's inclusion matters, since it's one of the few pheromone compounds actually studied in peer-reviewed contexts, and it belongs in a formula targeting emotional connection. But at $292 for the bundle, with no community field testing to lean on and no dosage transparency to evaluate, the risk-to-reward is poor. Enthusiast-grade alternatives with published compound concentrations exist at lower prices and have real forum-report histories to reference.
